The role of iron in the pathophysiology and treatment of chronic hepatitis C

被引:51
作者
Price, Leslie [1 ]
Kowdley, Kris V. [1 ]
机构
[1] Virginia Mason Med Ctr, Ctr Liver Dis, Seattle, WA 98101 USA
基金
美国国家卫生研究院;
关键词
Hemochromatosis; Hepatitis C; Iron overload; HEMOCHROMATOSIS GENE-MUTATIONS; INTERFERON-ALPHA THERAPY; CHRONIC VIRAL-HEPATITIS; OXIDATIVE DNA-DAMAGE; LONG-TERM RESPONSE; HEPATOCELLULAR-CARCINOMA; CONTROLLED-TRIAL; HFE GENE; LIVER-DISEASE; RISK-FACTORS;
D O I
10.1155/2009/290383
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Increased hepatic iron content may be observed in patients with chronic hepatitis C infection, and may contribute to disease severity. The presence of hemochromatosis gene mutations is associated with increased hepatic iron accumulation and may lead to accelerated disease progression. Hepatic iron depletion has been postulated to decrease the risk of hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. It is possible that iron depletion stabilizes or improves liver histology and slows disease progression in these individuals. The present article reviews the prevalence and risk factors for hepatic iron overload in chronic hepatitis C, with emphasis on the available data regarding the efficacy of iron depletion in the treatment of this common liver disease.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 60 条
[1]
Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study [J].
Alexander, Jacob ;
Tung, Bruce Y. ;
Croghan, Anne ;
Kowdley, Kris V. .
LIVER INTERNATIONAL, 2007, 27 (02) :268-273
[2]
Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis [J].
Boige, V ;
Castéra, L ;
de Roux, N ;
Ganne-Carrié, N ;
Ducot, B ;
Pelletier, G ;
Beaugrand, M ;
Buffet, C .
GUT, 2003, 52 (08) :1178-1181
[3]
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C [J].
Bonkovsky, Herbert L. ;
Naishadham, Deepa ;
Lambrecht, Richard W. ;
Chung, Raymond T. ;
Hoefs, John C. ;
Nash, S. Russell ;
Rogers, Thomas E. ;
Banner, Barbara F. ;
Sterling, Richard K. ;
Donovan, John A. ;
Fontana, Robert J. ;
Di Bisceglie, Adrian M. ;
Ghany, Marc G. ;
Morishima, Chihiro .
GASTROENTEROLOGY, 2006, 131 (05) :1440-1451
[4]
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C [J].
Bonkovsky, HL ;
Troy, N ;
McNeal, K ;
Banner, BF ;
Sharma, A ;
Obando, J ;
Mehta, S ;
Koff, RS ;
Liu, Q ;
Hsieh, CC .
JOURNAL OF HEPATOLOGY, 2002, 37 (06) :848-854
[5]
Iron and chronic viral hepatitis [J].
Bonkovsky, HL ;
Banner, BF ;
Rothman, AL .
HEPATOLOGY, 1997, 25 (03) :759-768
[6]
Carlo C, 2003, HEPATO-GASTROENTEROL, V50, P1467
[7]
Mutations of the HFE gene in patients, with hepatocellular carcinoma [J].
Cauza, E ;
Peck-Radosavljevic, M ;
Ulrich-Pur, H ;
Datz, C ;
Gschwantler, M ;
Schöniger-Hekele, M ;
Hackl, F ;
Polli, C ;
Rasoul-Rockenschaub, S ;
Müller, C ;
Wrba, F ;
Gangl, A ;
Ferenci, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (02) :442-447
[8]
Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis [J].
Chapoutot, C ;
Esslimani, M ;
Joomaye, Z ;
Ramos, J ;
Perney, P ;
Laurent, C ;
Fabbro-Peray, P ;
Larrey, D ;
Domergue, J ;
Blanc, F .
GUT, 2000, 46 (05) :711-714
[9]
HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload [J].
Coelho-Borges, S ;
Cheinquer, H ;
Cheinquer, N ;
Krug, L ;
Ashton-Prolla, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06) :1570-1572
[10]
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: A meta-analysis of six prospective randomized controlled trials [J].
Desai, Tusar K. ;
Jamil, Laith H. ;
Balasubramaniam, Mamtha ;
Koff, Raymond ;
Bonkovsky, Herbert L. .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (03) :815-822